Lisa Marie Babayan
Papers
1
Total Citations
133
H-Index
1
About
Dr. Lisa Marie Babayan is a leading gynecologic oncologist whose research focuses on optimizing perioperative care and reducing thrombotic complications in women with gynecologic malignancies. Her most impactful work, a 2020 study comparing apixaban to enoxaparin for preventing venous thromboembolism after surgery for gynecologic cancer, has garnered 133 citations and reshaped clinical practice. By demonstrating that a direct oral anticoagulant offers a safe, cost-effective, and more patient-friendly alternative to the standard 28-day enoxaparin regimen—which suffers from high costs and low adherence—Dr. Babayan addressed a critical gap in postoperative management. This contribution not only improved patient outcomes but also provided a pragmatic solution to a longstanding adherence challenge. Her research underscores a commitment to evidence-based, patient-centered care, and her findings have been widely adopted in clinical guidelines. Dr. Babayan’s work continues to influence how surgeons approach thromboprophylaxis, making her a pivotal figure in advancing the safety and quality of surgical oncology care.
Research Focus
Key Achievements
Top Papers
- 1